If you enjoy this content, please share it with a colleague
RELATED CONTENT
July 28, 2021 — IntraOp Medical Corporation announced that Lausanne University Hospital (CHUV, Switzerland) enrolled the ...
April 22, 2020 — IntraOp Medical Corporation announced the first patient enrolled in the Cosmopolitan Trial: A ...
The unfortunate reality of living with cancer is that oftentimes, the treatment can be just as much of a burden for patients as the disease itself.
Catherine Philippson, M.D., of the Jules Bordet Institute, Brussels presented her institution’s experience treating 425 early stage breast cancer patients from February 2010 through February 2014 using Mobetron to deliver intraoperative electron beam radiotherapy (IOERT) as the sole radiation treatment with no post-operative radiotherapy to follow.
The radiation therapy market, hit hard in 2009 by the recession, saw a sharp decline in purchasing from which it has slowly recovered. During the last five years the market has been steadily growing, with capital equipment budgets for radiation oncology sites increasing. However, it has only been within the last year that equipment purchases for radiation therapy have leveled out. Purchasing decisions today are driven by two main factors: advancements in technology, including more targeted treatment, multifunctional capabilities and improved patient safety; and the evolving reimbursement model, which weighs patient outcomes and the quality of care delivered more heavily.
August 21, 2012 — Ospedale Borgo Trento in Verona, Italy, recently published a study of 226 women with early-stage breast cancer that received a single dose of intraoperative electron radiation therapy (IOERT) using the IntraOp Mobetron from IntraOp Medical Corp. during surgery.
September 3, 2008 - IntraOp will discuss at ASTRO 2008 the recent results of the study which found that a single dose of ...
June 27, 2008 - IntraOp Medical released the results of a study which shows that, for women with breast cancer, a single ...
April 2, 2008 — IntraOp Medical Corp. received an order for the Mobetron from the Instituto Nacional de Cancerologia, in ...
March 12, 2008 - Doctors at Nagoya University Hospital in Nagoya, Japan, are using the Mobetron, self-shielding linear ...